Inventor
SENGUPTA DIPANJAN
US37 patents
⚠️ This page may combine multiple inventors who share the name “SENGUPTA DIPANJAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTEL CORP
11 patentsUS11500887B2Nov 15, 2022
Technologies for tuning performance and/or accuracy of similarity search using stochastic associative memories
INTEL CORP2 citations71
US11989553B2May 21, 2024
Technologies for performing sparse lifting and procrustean orthogonal sparse hashing using column read-enabled memory
INTEL CORP1 citations61
US11574172B2Feb 7, 2023
Technologies for performing efficient memory augmented neural network update operations
INTEL CORP0 citations61
US11392494B2Jul 19, 2022
Technologies for performant column read operations on clustered data in a dimm architecture
INTEL CORP1 citations61
US11327881B2May 10, 2022
Technologies for column-based data layouts for clustered data systems
INTEL CORP0 citations61
US11853766B2Dec 26, 2023
Technology to learn and offload common patterns of memory access and computation
INTEL CORP1 citations60
US11507773B2Nov 22, 2022
Large-scale similarity search with on-chip cache
INTEL CORP1 citations60
US11403102B2Aug 2, 2022
Technology to learn and offload common patterns of memory access and computation
INTEL CORP0 citations60
US12535972B2Jan 27, 2026
Avoiding partition collisions in stochastic associative memory for data stored across multiple partitions
INTEL CORP0 citations50
US11829376B2Nov 28, 2023
Technologies for refining stochastic similarity search candidates
INTEL CORP0 citations50
US11604834B2Mar 14, 2023
Technologies for performing stochastic similarity searches in an online clustering space
INTEL CORP0 citations50
ARENA PHARM INC
8 patentsUS9447041B2Sep 20, 2016
Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC12 citations91
US9175320B2Nov 3, 2015
Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC15 citations91
US11149292B2Oct 19, 2021
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC8 citations83
US8367657B2Feb 5, 2013
Processes for preparing 3-benzazepines
ARENA PHARM INC9 citations81
US7425630B2Sep 16, 2008
Processes for preparing pyrazolo[3,4-d]pyrimidine ethers
ARENA PHARM INC14 citations79
US11674163B2Jun 13, 2023
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
ARENA PHARM INC0 citations61
US9199940B2Dec 1, 2015
Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor
ARENA PHARM INC1 citations60
US9783502B2Oct 10, 2017
Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor
ARENA PHARM INC0 citations49
MIRAVANT PHARM INC
3 patentsUS6794505B1Sep 21, 2004
Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy
MIRAVANT PHARM INC20 citations92
US5973141AOct 26, 1999
Method for the demethoxycarbonylation of porphyrinic compounds such as pheophorbides
MIRAVANT PHARM INC26 citations89
US7521551B2Apr 21, 2009
Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy
MIRAVANT PHARM INC0 citations51
DART NEUROSCIENCE CAYMAN LTD
3 patentsUS9150572B2Oct 6, 2015
Substituted naphthyridine and quinoline compounds as MAO inhibitors
DART NEUROSCIENCE CAYMAN LTD2 citations61
US9102674B2Aug 11, 2015
Substituted naphthyridine and quinoline compounds as MAO inhibitors
DART NEUROSCIENCE CAYMAN LTD2 citations61
US9956213B2May 1, 2018
Substituted naphthyridine and quinoline compounds as MAO inhibitors
DART NEUROSCIENCE CAYMAN LTD0 citations50